Change of Nominated Adviser and Broker

RNS Number : 3192L
Circassia Group Plc
12 January 2021
 

Circassia Group plc

Change of Nominated Adviser and Broker 

 

Oxford, UK - 12 January 2021:   Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on respiratory diagnostics and monitoring , today announces that N+1 Singer has been appointed as the Company's nominated adviser and sole broker with immediate effect.

 

 -Ends-

For further information, please contact:

Circassia

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

Sarah Duncan, Company Secretary

 


Tel:  +44(0)1865 405566

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Jen Boorer / Hannah Woodley  

 


Tel: +44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPZZGMMMMNGMZZ

Companies

Niox Group (NIOX)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today